Related Experiment Videos
Vancomycin-induced thrombocytopenia: a case proven with rechallenge
Jeanna Marraffa1, Roy Guharoy, David Duggan
1Department of Pharmacy, University Hospital, State University of NewYork-Upstate Medical University, Syracuse, New York 13210, USA.
Pharmacotherapy
|October 4, 2003
Summary
Vancomycin can cause a dangerous drop in platelet count (thrombocytopenia), even after initial treatment. Promptly switching to clindamycin and prednisone improved the patient's condition and restored platelet levels.
Area of Science:
- Internal Medicine
- Pharmacology
- Hematology
Background:
- Subacute bacterial endocarditis requires effective antibiotic treatment.
- Vancomycin is a common antibiotic used for Gram-positive bacterial infections.
- Drug-induced thrombocytopenia is a known, albeit rare, adverse effect of certain medications.
Observation:
- A patient developed severe thrombocytopenia post-mitral valve replacement surgery while on vancomycin.
- Platelet count dropped significantly, and antiheparin antibodies were detected, initially suggesting heparin-induced thrombocytopenia.
- Despite transfusions and other interventions, the patient's condition worsened until vancomycin was discontinued.
Findings:
- The patient's thrombocytopenia resolved after vancomycin was replaced with clindamycin and methylprednisolone (later prednisone).
- A subsequent single dose of vancomycin in the hospital precipitated a rapid decline in platelet count, strongly suggesting vancomycin as the causative agent.
- This case highlights a rare instance of vancomycin-induced thrombocytopenia.
Implications:
- Clinicians should consider vancomycin-induced thrombocytopenia in patients presenting with unexplained thrombocytopenia during or after vancomycin therapy.
- Early recognition and discontinuation of vancomycin are crucial for patient recovery.
- This case underscores the importance of vigilant monitoring for adverse drug reactions, particularly in complex surgical and medical cases.